Versant Venture Capital Vii, L's Net Worth

Versant Venture Capital Vii, L's net worth is estimated to be at least $16,740,000.00 as of 10/05/2022. CoreStreet's estimation of Versant Venture Capital Vii, L's net worth is based on their sale of stock and current holding of stock.

Versant Venture Capital Vii, L is Major Shareholder at Chinook Therapeutics Inc. They have executed at least 2 trades of stock as per SEC Form 4 filings. Their most recent trade was for 600,000 units of KDNY stock on 01/03/2022. Their biggest sale was on 01/03/2022 when they sold 600,000 units of Chinook Therapeutics Inc stock for $9,600,000.00. They typically trade 1 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $16,740,000.00
Most recent insider trade:
  • Jan. 3, 2022

Versant Venture Capital Vii, L's Insider Trading History

Chinook Therapeutics IncTitleAmountPriceTypeTotal Value
Jan. 3, 2022
Major Shareholder600,000$16.00Sell$9,600,000.00
Aug. 27, 2021
Major Shareholder510,000$14.00Sell$7,140,000.00